Crossmark

Frequency of next-generation sequencing, prevalence of targetable mutations and response to targeted therapies amongst patients with metastatic urothelial cancer in Ireland: a multi-centre retrospective study of real-world data

Crossref DOI link: https://doi.org/10.1007/s11845-023-03569-2

Published Online: 2023-11-10

Published Print: 2024-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ronan, Karine https://orcid.org/0000-0002-1828-5708
Jordan, Emmet

Leonard, Christine

McDermott, Ray
License Information

Text and Data Mining valid from 2023-11-10

Version of Record valid from 2023-11-10
More Information

Article History

Received: 16 July 2023

Accepted: 1 November 2023

First Online: 10 November 2023

Declarations

:

: This study was granted approval by the Research Ethics Committee HSE South Eastern Area. This study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below